RxDoctor Payments Data

Kanaiyalal Patel, MD

Sleep Medicine · Greenbelt, MDNPI 1295737914

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.6% of the total across 139 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 23.2% — the pattern of someone who eats at a lot of different presentations.

$2,764in general payments, 2019–2025

Across 139 payments — averaging $19.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Optinose US, Inc.$640
  • Jazz Pharmaceuticals Inc.$597
  • GSK$534
  • Sanofi$273
  • Regeneron Healthcare Solutions, Inc.$252
  • Inspire Medical Systems, Inc.$193
  • plus $275 from 9 others

What the payments were for

  • Consulting fees$1505%
  • Food & beverage$2,61495%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,764 in reported general payments places this provider in the 80th percentile of 41 sleep medicine providers in Maryland.

See all sleep medicine providers in Maryland

Medicare billing

Part B allowed, 2024
$243,126
Medicare patients
899
Services billed
2,001

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Epinephrine17$2,635
Fluticasone Propionate95$2,214
Ofloxacin46$1,641
Azelastine Hcl40$1,391
Omeprazole105$1,288
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth12$1,200
Fluocinolone Acetonide Oil21$1,122
Ipratropium Bromide19$465
Insulin SyringeSyringe And Needle,insulin,1ml12$456
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$164
Mupirocin17$111
Chlorhexidine Gluconate13$48

Paid to pharmacies, not to this prescriber.

Other sleep medicine in Greenbelt

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →